Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in PRLD — Prelude Therapeutics Inc

CIK 886982 NEW YORK, NY
Back to PRLD Full portfolio

Position in PRLD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$644,044
-$164,679 QoQ
Shares Held
120,834
-48.9% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 75 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. PRLD ranks #275 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in PRLD

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $644,044 120,834
2026-03-31 $808,723 236,469
2025-12-31 $340,683 117,477
2025-09-30 $114,230 79,327
2025-06-30 $120,685 149,178
2025-03-31 $119,204 155,215
2024-12-31 $189,115 148,326
2024-09-30 $196,983 95,161
2024-06-30 $285,456 74,923
2024-03-31 $319,603 67,427
2023-12-31 $296,615 69,465
2023-09-30 $209,155 67,688
2023-06-30 $107,046 23,788
2023-03-31 $282,127 49,496
2022-12-31 $95,214 15,764
2022-09-30 $143,668 21,735
2022-06-30 $231,219 44,295
2022-03-31 $166,220 24,090
2021-12-31 $1,411,020 113,335
2021-09-30 $270,593 8,659
2021-06-30 $533,004 18,617
2021-03-31 $1,885,244 43,509
2020-09-30 $2,506,816 83,200